51 PROGNOSTIC IMPACT OF TRANSFUSION INTENSITY ON SURVIVAL AND THROMBOCYTOPENIA IN NEWLY DIAGNOSED LOWER-RISK MDS PATIENTS PARTICIPATING IN THE EUROPEAN LEUKEMIANET MDS (EUMDS) REGI... von de Swart, L, Johnston, W.T, Smith, A, Fenaux, P, Symeonidis, A, Cermak, J, Hellström-Lindberg, E, Sanz, G, Stauder, R, Malcovati, L, Germing, U, Huls, G, Holm, M.S, Mittelman, M, Madry, K, Tatic, A, Almeida, A.M, Savic, A, Park, S, Beyne-Rouzy, O, Itzykson, R, Droste, J, Bowen, D, de Witte, T

Volltext

Thalidomide for the Treatment of Low Risk Myelodysplasia von Bouscary, D., Quarre, M.C., Vassilief, D., Rouzy, O. Beyne, Aouba, A., Berthou, C., Gardembas, C., Sanhes, L., Guerci, A., Mahe, B., Stamatoullas, A., Bauduer, F., Sotto, J.J., Legros, L., Vaultier, S., Fenaux, P., Dreyfus, F.

Volltext